Stem cell-based therapy for malignant glioma
Authors:
- Daniel BexellDBDaniel Bexell
- Andreas SvenssonASAndreas Svensson
- Johan BengzonJBJohan Bengzon
Open Access
- 1 June 2013
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 39 (4) , 358-365
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialThe Lancet Oncology, 2009
- Malignant Gliomas in AdultsNew England Journal of Medicine, 2008
- Gene Therapy for Malignant Glioma: Current Clinical StatusMolecular Therapy, 2005
- Genetic strategies for brain tumor therapyCancer Gene Therapy, 2005
- Lessons from the bone marrow: how malignant glioma cells attract adult haematopoietic progenitor cellsBrain, 2005
- Human Bone Marrow–Derived Mesenchymal Stem Cells in the Treatment of GliomasCancer Research, 2005
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma modelGene Therapy, 2004
- Development of novel targeted therapies in the treatment of malignant gliomaNature Reviews Drug Discovery, 2004
- Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomasProceedings of the National Academy of Sciences, 2000